{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-021663","form_type":"8-K","ticker":"PIII","cik":"0001832511","company_name":"P3 Health Partners Inc.","filed_at":"2024-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.563757+00:00","generated_at":"2026-06-02T12:54:03.693644+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"P3 Health Partners Q1 revenue up 29% to $388.5M; appoints Dr. Aric Coffman as CEO","bullets":["Total revenue $388.5M (+29% YoY); capitated revenue $384.1M; net loss improved to $49.6M from $52.4M.","Medical margin $36.6M vs $39.2M prior year; gross profit fell to $6.4M from $16.5M.","Reaffirms FY2024 guidance: revenue $1.45-1.55B, medical margin $230-250M, adjusted EBITDA $20-40M.","Dr. Aric Coffman appointed CEO; company anticipates reaching adjusted EBITDA positive in 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-021663","json":"https://secwatch.observer/filing/0001628280-24-021663.json","markdown":"https://secwatch.observer/filing/0001628280-24-021663.md","text":"https://secwatch.observer/filing/0001628280-24-021663.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832511/000162828024021663/0001628280-24-021663-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832511/000162828024021663/piii-20240508.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T12:54:03.693644+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"15555172ca49bf553619a2b5f920dd62fa21db9f","claim":"P3 Health Partners Inc. updated its first quarter ended March 31, 2024 guidance (reaffirmed).","evidence_excerpt":"On May 8, 2024, P3 Health Partners Inc. (the “Company”) announced its financial results for the three months ended March 31, 2024. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K (the “Report”).","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832511/000162828024021663/0001628280-24-021663-index.htm","confidence":0.7,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}